News

Filter

Current filters:

DiabetesKombiglyze

FDA to review heart failure risk with AstraZeneca diabetes drug

FDA to review heart failure risk with AstraZeneca diabetes drug

12-02-2014

The US Food and Drug Administration has requested clinical trial data from Anglo-Swedish drug major AstraZeneca,…

AstraZenecaDiabetesKombiglyzeNorth AmericaOnglyzaPharmaceuticalRegulationResearchUSA

US FDA clears AstraZeneca/Bristol-Myers combo diabetes drug Kombiglyze XR

08-11-2010

The US Food and Drug Administration approved Kombiglyze XR, a drug resulting from a 2007 collaboration…

AstraZenecaBristol-Myers SquibbDiabetesKombiglyzeNorth AmericaPharmaceuticalRegulation

Back to top